Amanda Black profile picture

Contact Information

Amanda Black, MD, MPH, FRCSC
613-738-8400 x81799

ORCID logo https://orcid.org/0000-0002-2245-3428

Amanda Black

Associate Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Professor, Dept Obstetrics and Gynecology
University of Ottawa
Vice Chair Research, Dept of Obstetrics and Gynecology
Dr. Elaine Jolly Chair in Women's Health Research, Dept of Obstetrics and Gynecology
Medical Director, Shirley E. Greenberg Women's Health Centre
The Ottawa Hospital
Chair, National Contraception Awareness Program
Society of Obstetricians and Gynecologists of Canada (SOGC)

Research Interests

Brief Biography

Dr. Amanda Black is a Professor of Obstetrics and Gynecology at The University of Ottawa.  She completed her training at the University of Western Ontario, the University of Ottawa, and Queen's University, and a Masters of Public Health at Johns Hopkins University. She holds appointments at The Ottawa Hospital and the Children's Hospital of Eastern Ontario and is an Associate Scientist at the Ottawa Hospital Research Institute. Her subspecialty areas of interest are Contraception/Family Planning and Adolescent Health. She is an active member of the Society of Obstetricians and Gynecologists of Canada (SOGC), has authored several national guidelines, has developed many educational programs, has presented nationally and internationally, and authored numerous publications in her field.

Dr. Black holds the Dr. Elaine Jolly Chair in Women's Health Research at The University of Ottawa.  She has participated in a number of international clinical trials, database studies, and investigator-led clinical studies.  Her research focuses on new contraceptive methods, contraceptive use and trends in Canada, access to family planning services, and adolescent sexual health.

Selected Publications

  • Black A, Guilbert E, Costecu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, et al.  Canadian Contraception Consensus/Consensus canadien sur la contraception (Part 3 of 4).  Progestin-Only Contraception.  J Obstet Gynecol Can Mar 2016; 38(3): 279-300 
  •  Black A, Guilbert E, Costecu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, et al.  Canadian Contraception Consensus/Consensus canadien sur la contraception (Part 3 of 4).  Intrauterine Contraception/Contraception Intra-utérine.  J Obstet Gynecol Can Feb 2016; 38(2): 182-222
  • Black A, Guilbert E, Costecu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, et al.  Canadian Contraception Consensus/Consensus canadien sur la contraception (Part 2 of 4).  J Obstet Gynecol Can Nov 2015; 37(11): S1-39
  • Black A, Guilbert E, Costecu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, et al.  Canadian Contraception Consensus/Consensus canadien sur la contraception (Part 1 of 4).  J Obstet Gynecol Can Oct 2015; 37(10): S1-28
  • Rotermann M, Dunn S, Black A.  Oral contraceptive use among women aged 15 to 49: Results from the Canadian Health Measures Survey. Health Reports Oct 2015; 26(10):  21-28    
  • Black AY, Guilbert E, Hassan F, Chatzitheofiliou I, Jeddi M, Filnenko A, Trussell J.  The Cost of Unintended Pregnancies (CoUP) in Canada:  Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives.  J Obstet Gynaecol Canada Dec 2015; 37(12): 1086-1097.

Diseases, conditions and populations of interest





Research and clinical approaches